Literature DB >> 31081022

Challenge of drug resistance in Pseudomonas aeruginosa: clonal spread of NDM-1-positive ST-308 within a tertiary hospital.

Ka Lip Chew1, Sophie Octavia2, Oon Tek Ng3,4,5, Kalisvar Marimuthu3,4,6, Indumathi Venkatachalam7, Bernadette Cheng1, Raymond T P Lin1,2, Jeanette W P Teo1.   

Abstract

OBJECTIVES: MDR Pseudomonas aeruginosa is a serious global threat to healthcare institutions. The mechanism by which drug resistance can be acquired is variable, but acquired carbapenemase production has been reported in P. aeruginosa. An investigation was performed to determine the rate and genomic epidemiology of New Delhi MBL (NDM) in β-lactam-non-susceptible isolates.
METHODS: P. aeruginosa isolates from a tertiary hospital in Singapore between January 2015 and February 2018 were investigated for the presence of NDM genes.
RESULTS: Out of 298 pan-β-lactam-non-susceptible isolates, 31 were found to be NDM positive (10.4%). WGS demonstrated that all 31 NDM-positive isolates were clonal, belonging to ST-308. blaNDM was chromosomally inserted within an integrative and conjugative element (ICE), ICETn43716385. The NDM-P. aeruginosa isolates possessed an extensive repertoire of both cell-associated [flagella, pili, alginate/biofilm, LPS, type III secretion system (T3SS) and type VI secretion system (T6SS)] and secreted virulence factors. Antibiograms revealed higher rates of drug resistance in NDM-positive isolates compared with their non-NDM counterparts. The NDM isolates remained 100% susceptible only to colistin.
CONCLUSIONS: The combination of chromosomal mutations, acquired resistance genes and virulence factors likely facilitated the persistent and ongoing spread of the ST-308 clade of P. aeruginosa within the hospital. Our study illustrates the particular threat of NDM-positive P. aeruginosa in a tertiary hospital setting in the era of antimicrobial resistance.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31081022     DOI: 10.1093/jac/dkz169

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

Review 1.  The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria.

Authors:  Dalal Hammoudi Halat; Carole Ayoub Moubareck
Journal:  Antibiotics (Basel)       Date:  2020-04-16

2.  High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.

Authors:  Gertrudis Horna; Catherine Amaro; Aida Palacios; Humberto Guerra; Joaquim Ruiz
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

3.  Novel Chromosome-Borne Accessory Genetic Elements Carrying Multiple Antibiotic Resistance Genes in Pseudomonas aeruginosa.

Authors:  Ting Yu; Huiying Yang; Jun Li; Fangzhou Chen; Lingfei Hu; Ying Jing; Xinhua Luo; Zhe Yin; Mingxiang Zou; Dongsheng Zhou
Journal:  Front Cell Infect Microbiol       Date:  2021-03-18       Impact factor: 5.293

4.  Retrospective Data Insight into the Global Distribution of Carbapenemase-Producing Pseudomonas aeruginosa.

Authors:  Min-Ge Wang; Zhi-Yong Liu; Xiao-Ping Liao; Ruan-Yang Sun; Run-Bo Li; Yan Liu; Liang-Xing Fang; Jian Sun; Ya-Hong Liu; Rong-Min Zhang
Journal:  Antibiotics (Basel)       Date:  2021-05-09

5.  Molecular Epidemiology of Fosfomycin Resistant E. coli from a Pigeon Farm in China.

Authors:  Lu Han; Xiao-Qing Lu; Xu-Wei Liu; Mei-Na Liao; Ruan-Yang Sun; Yao Xie; Xiao-Ping Liao; Ya-Hong Liu; Jian Sun; Rong-Min Zhang
Journal:  Antibiotics (Basel)       Date:  2021-06-25

6.  Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore.

Authors:  Jocelyn Qi-Min Teo; Cheng Yee Tang; Jie Chong Lim; Shannon Jing-Yi Lee; Si Hui Tan; Tse-Hsien Koh; James Heng-Chiak Sim; Thuan-Tong Tan; Andrea Lay-Hoon Kwa; Rick Twee-Hee Ong
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.